http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008136188-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate | 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008136188-A |
| titleOfInvention | ANTI-CANCER PHARMACEUTICAL COMPOSITION |
| abstract | 1. An anti-cancer pharmaceutical composition for the prevention or treatment of stomach cancer, colon cancer, lung cancer, breast cancer, pancreatic cancer, kidney cancer, prostate cancer, medulloblastoma, rhabdomyosarcoma, Ewing sarcoma, liposarcoma, multiple myeloma or leukemia, containing as an active ingredient, a compound represented by the following general formula (I):! ! wherein ! R represents a phenyl group substituted by 1-5 groups selected from the group of substituents α, and! X represents an oxygen atom or a sulfur atom; ! <substituent group α>: halogen atom, hydroxy group, C1-C6 alkyl group, halogen C1-C6 alkyl group, C1-C6 alkoxy group, C1-C6 alkylthio group, amino group which may be substituted by 1 or 2 groups selected from the group of substituents γ, C3-C10 cycloalkyl, A C6-C10 aryl, C7-C16 aralkyl, C6-C10 aryloxy, C7-C16 aralkyloxy or C6-C10 arylthio group which may be substituted by 1-3 groups selected from the substituent group β, a C1-C7 aliphatic acyloxy group, a 4-7 membered saturated heterocyclic group containing nitrogen atom (s), 5-6 membered aromatic a heterocyclic group containing a nitrogen atom (s), a nitro group and a cyano group; ! <substituent group β>: a halogen atom, a hydroxy group, a C1-C6 alkyl group, a halogen C1-C6 alkyl group, a C1-C6 alkoxy group, an amino group which may be substituted with 1 or 2 groups selected from the substituent group γ, a C6-C10 aryl group and a nitro group; ! <substituent group γ>: C1-C10 alkyl group, C6-C10 aryl group, C7-C16 aralkyl group, C1-C7 aliphatic acyl group, C7-C11 aromatic acyl group, C8-C12 aromatic |
| priorityDate | 2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.